These results, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the strategy of focusing on ACKR3 as a singular approach to modulate the opioid program, which could open new therapeutic avenues for opioid-related Diseases. A study examine released in https://lorenzo502avp0.homewikia.com/user